Risk factors for lethal outcomes after surgical treatment of patients with chronic periprosthetic hip joint infection
https://doi.org/10.18019/1028-4427-2021-27-5-555-561
Abstract
Abstract. Introduction Periprosthetic joint infections (PJI) are serious complications of total hip arthroplasty (THA) and affect the patient's life expectancy.
The aim of the study was to identify independent factors influencing the risk of death in patients with PJI after revision THA. Materials and methods The study
included 51 lethal outcomes in patients with chronic PJI of the hip. Results and discussion In our cohort of 434 patients, 13 (2.99 %) patients died within
the first year after surgery (p > 0.05), which is 2.2 times less than similar published data. The result of gender analysis showed no statistically significant
differences in the risk of death between men and women (OR1.05 CI 0.59–1.89, p = 0.87). It was found that in patients over 70 years old, the risk of death
was significantly higher (OR 2.05 CI 1.09–3.87, p = 0.031). Additional independent risk factors of death are diseases of the cardiovascular system. It was not
possible to find a statistically significant effect of the nature of infection on the risk of death: no growth (OR 2.23, CI 0.52–9.61), monomicrobial infection
(OR 1.98, CI 0.45–8, 73), polymicrobial infection (OR 3.2, CI 0.71–14.45, p > 0.05). Conclusion The mortality rate during the first year after revision THA
in patients with PJI was 2.99 %, which is lower than the results of other researchers. In the next 2–3 years, the rate of death increases 3.9 times. The main
independent risk factors are the age of patients and concomitant diseases of the cardiovascular system.
About the Authors
V.A. ArtyukhRussian Federation
S.A. Bozhkova
Russian Federation
R.M. Tikhilov
Russian Federation
A.V. Yarmilko
Russian Federation
Yu.V. Muravyova
Russian Federation
Review
For citations:
Artyukh V., Bozhkova S., Tikhilov R., Yarmilko A., Muravyova Yu. Risk factors for lethal outcomes after surgical treatment of patients with chronic periprosthetic hip joint infection. Genij Ortopedii. 2021;27(5):555-561. https://doi.org/10.18019/1028-4427-2021-27-5-555-561